Manufacturers will not be required to recall or relabel medicines already released in the market before September 22, following the latest revision in GST rates. The National Pharmaceutical Pricing Authority (NPPA) said the companies must ensure price compliance at the retailer level. "The…companies shall issue revised price list…to dealers and retailers for display to consumers," NPPA said.